4//SEC Filing
Hatfield Jeffrey S. 4
Accession 0000899243-21-005208
CIK 0001590750other
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 5:40 PM ET
Size
9.7 KB
Accession
0000899243-21-005208
Insider Transaction Report
Form 4
Hatfield Jeffrey S.
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2021-02-04+25,000→ 25,000 totalExercise: $20.50Exp: 2031-02-04→ Common Stock (25,000 underlying)
Footnotes (1)
- [F1]The option vest monthly over a three year period, subject to Reporting Person's continued service on the Board.
Issuer
Viridian Therapeutics, Inc.\DE
CIK 0001590750
Entity typeother
Related Parties
1- filerCIK 0001609879
Filing Metadata
- Form type
- 4
- Filed
- Feb 7, 7:00 PM ET
- Accepted
- Feb 8, 5:40 PM ET
- Size
- 9.7 KB